Loading chat...

AL HB433

Bill

Official Source

Status

Introduced

5/3/2023

Primary Sponsor

Frances Holk-Jones

Click for details

Origin

House of Representatives

Regular Session 2023

AI Summary

  • Repeals the Medication Assisted Treatment of Opioid Use Act of 2019 (Sections 20-2-300 through 20-2-302, Code of Alabama 1975)
  • Eliminates the requirement for the Alabama Board of Medical Examiners to adopt rules governing the prescribing and use of buprenorphine for treating opioid addiction in nonresidential settings
  • Removes the standing working group of addiction specialists that was established to assist in drafting treatment rules
  • Becomes effective on the first day of the third month following passage and approval by the Governor

Legislative Description

Relating to Opioid Addiction Treatment; to repeal the Medication Assisted Treatment of Opioid Use Act of 2019, codified as Sections 20-2-300 through 20-2-302, Code of Alabama 1975, that provide for adoption of rules governing use of buprenorphine in the treatment of opioid addiction and a standing working group to assist in drafting the rules.

Medication Assisted Treatment of Opioid Use Act, repealed

Last Action

Indefinitely Postpone

5/31/2023

Committee Referrals

Health5/3/2023

Full Bill Text

No bill text available